Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with non-alcoholic fatty liver disease
- PMID: 21382273
Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with non-alcoholic fatty liver disease
Abstract
Non-alcoholic fatty liver disease, characterized by hepatocyte apoptosis, is distinct in fatty liver and non-alcoholic steatohepatitis, the more severe form. Apoptotic cell death is caspase-dependent and associated with mitochondrial membrane depolarization and cytochrome c release. Adhering to the hypothesis that the exposure of hepatocytes to free fatty acids, resulting in increased ROS production and mitochondrial damage, is balanced by the presence of antioxidant substances, circulating levels of gamma-glutamyl transferase, cytochrome c, triglycerides and unconjugated bilirubin were explored in patients suffering from non-alcoholic fatty liver disease with different severity. One hundred and eighty-six consecutive patients who presented recent ultrasound feature of bright liver without any liver disease of known origin were enrolled, eighty-nine of whom underwent liver biopsy. Forty-five subjects were allocated on the basis of histology in fatty liver group while 44 patients formed the group with non-alcoholic steatohepatitis. A cohort of 27 young, lean, apparently healthy individuals was selected as control group. The levels of gamma-glutamyl transferase were normal or slightly increased, while unconjugated bilirubin concentrations were elevated in all the spectra of non-alcoholic fatty liver disease. Comparing the present results with relevant findings from other studies dealing with diseases characterized by apoptosis, we did not find high circulating levels of cytochrome c in non-alcoholic fatty liver disease. What is more, our patients, categorized as suffering from simple fatty liver or from the more severe non-alcoholic steatohepatitis, had similar levels of cytochrome c and gamma-glutamyl transferase, p=0.19 and 0.11. Serum triglycerides were higher in patients with non-alcoholic fatty liver disease than in the healthy group, p=0.001. These findings likely reflect a balance between oxidative stress and anti-oxidant response rather than a lack of reliability of cytochrome c as a reliable biomarker of mitochondrial damage.
Similar articles
-
Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease.World J Gastroenterol. 2011 Dec 28;17(48):5280-8. doi: 10.3748/wjg.v17.i48.5280. World J Gastroenterol. 2011. PMID: 22219597 Free PMC article.
-
Unconjugated bilirubin, a potent endogenous antioxidant, is decreased in patients with non-alcoholic steatohepatitis and advanced fibrosis.J Gastroenterol Hepatol. 2013 Jul;28(7):1202-8. doi: 10.1111/jgh.12155. J Gastroenterol Hepatol. 2013. PMID: 23425054
-
Unconjugated hyperbilirubinemia is inversely associated with non-alcoholic steatohepatitis (NASH).Aliment Pharmacol Ther. 2012 Jun;35(12):1416-23. doi: 10.1111/j.1365-2036.2012.05114.x. Epub 2012 Apr 29. Aliment Pharmacol Ther. 2012. PMID: 22540836
-
Effects of red wine on postprandial stress: potential implication in non-alcoholic fatty liver disease development.Eur J Nutr. 2015 Jun;54(4):497-507. doi: 10.1007/s00394-015-0877-2. Epub 2015 Mar 16. Eur J Nutr. 2015. PMID: 25772634 Review.
-
[Gamma glutamyl transpeptidase (gammaGTP) in the era of metabolic syndrome].Nihon Arukoru Yakubutsu Igakkai Zasshi. 2007 Jun;42(3):110-24. Nihon Arukoru Yakubutsu Igakkai Zasshi. 2007. PMID: 17665541 Review. Japanese.
Cited by
-
What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?World J Gastroenterol. 2013 Jun 14;19(22):3375-84. doi: 10.3748/wjg.v19.i22.3375. World J Gastroenterol. 2013. PMID: 23801829 Free PMC article. Review.
-
Association of Serum Bilirubin and Functional Variants of Heme Oxygenase 1 and Bilirubin UDP-Glucuronosyl Transferase Genes in Czech Adult Patients with Non-Alcoholic Fatty Liver Disease.Antioxidants (Basel). 2021 Dec 15;10(12):2000. doi: 10.3390/antiox10122000. Antioxidants (Basel). 2021. PMID: 34943103 Free PMC article.
-
Relevance of proteolysis and proteasome activation in fatty liver graft preservation: An Institut Georges Lopez-1 vs University of Wisconsin appraisal.World J Gastroenterol. 2017 Jun 21;23(23):4211-4221. doi: 10.3748/wjg.v23.i23.4211. World J Gastroenterol. 2017. PMID: 28694661 Free PMC article.
-
High Intrinsic Aerobic Capacity Protects against Ethanol-Induced Hepatic Injury and Metabolic Dysfunction: Study Using High Capacity Runner Rat Model.Biomolecules. 2015 Nov 20;5(4):3295-308. doi: 10.3390/biom5043295. Biomolecules. 2015. PMID: 26610588 Free PMC article.
-
Correlation of Adiponectin Gene Polymorphisms rs266729 and rs3774261 With Risk of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.Front Endocrinol (Lausanne). 2022 Mar 23;13:798417. doi: 10.3389/fendo.2022.798417. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35399941 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical